These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21944866)

  • 1. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
    Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
    Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
    Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
    Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of the IGF-1 gene rs35767 and rs17032362 polymorphisms in the etiology of idiopathic short stature.
    Tekcan D; Baş F; Atalar F; Aydin BK; Akan G; Tarhan T; Bundak R; Darendeliler F
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):395-400. PubMed ID: 22689104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.
    Rietveld I; Janssen JA; van Rossum EF; Houwing-Duistermaat JJ; Rivadeneira F; Hofman A; Pols HA; van Duijn CM; Lamberts SW
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):195-203. PubMed ID: 15272914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
    Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
    Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.
    Deal C; Ma J; Wilkin F; Paquette J; Rozen F; Ge B; Hudson T; Stampfer M; Pollak M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1274-80. PubMed ID: 11238520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR; Shafiei N; Safarinejad S
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study.
    Clayton P; Bonnemaire M; Dutailly P; Maisonobe P; Naudin L; Pham E; Zhang Z; Grupe A; Thiagalingam A; Denèfle P;
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1122-30. PubMed ID: 23596138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
    Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
    Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocrine consequences for very low birth weight premature infants.
    Cutfield WS; Regan FA; Jackson WE; Jefferies CA; Robinson EM; Harris M; Hofman PL
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.